Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction.
about
Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screeningImpact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytesRegulation of mitochondrial poly(ADP-Ribose) polymerase activation by the β-adrenoceptor/cAMP/protein kinase A axis during oxidative stress.Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and punctureAP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial CellsDevelopment of a stretch-induced neurotrauma model for medium-throughput screening in vitro: identification of rifampicin as a neuroprotectant.Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes.The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro.Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspectsA mitochondrial bioenergetic basis of depression.Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction.Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo.Teaching an old drug new tricks: can paroxetine ease the burden of cardiovascular disease in diabetes?Co-medication of pravastatin and paroxetine-a categorical study.Effect of Imipramine, Paroxetine, and Lithium Carbonate on Neurobehavioral Changes of Streptozotocin in Rats: Impact on Glycogen Synthase Kinase-3 and Blood Glucose Level.Hydrogen Sulfide Selectively Inhibits γ-Secretase Activity and Decreases Mitochondrial Aβ Production in Neurons from APP/PS1 Transgenic Mice.In the View of Endothelial Microparticles: Novel Perspectives for Diagnostic and Pharmacological Management of Cardiovascular Risk during Diabetes Distress.
P2860
Q28533928-0B97835A-62C3-4142-8899-5CEFDEB8F925Q33845592-4DEF4134-EFA7-443F-A28E-FFAEEF38E54CQ34129753-C0D9E26A-D80D-4D28-ADF9-BCEAEC7F9C98Q34186029-D5824EA0-8AB9-4446-B3A4-A2685C8FE9EEQ34256015-673AC115-D56F-416D-8799-49D8693DB783Q34477537-D4DB2AAE-F8FA-4A13-B16D-5917E3578C57Q36003163-BE3BA6D4-4393-4282-800E-C7534A756666Q36159089-25C8B835-84BE-4E78-B537-137F95012ACDQ36211215-9AF18F4A-C507-48C8-88CC-59035DFAC86EQ37420836-F7A6780C-8264-4B1F-848D-2D6C704E785BQ37686288-F02C628E-6BDE-40B8-A47B-2BD6DB52F180Q38254909-06F142B9-CC8C-406D-B591-59947564C35FQ41237165-FADCEDB3-DBA1-499D-B586-D17A954DCBF5Q41841136-153B17AC-1531-47BE-892E-0C40E748D94BQ43240743-B3E10F70-2AB1-44D2-9FCD-AEBE6F7B7AB4Q44062694-5E6B02A1-8769-41C5-B6F3-D73910A09572Q46866200-12FD7483-3CE8-4BFE-A98A-3BB08DE5C5D3Q49093504-F011E609-3A05-4413-A5F2-F2EB2505BC4DQ54972391-9224B1F3-007C-436A-920E-B09EEA57A8B3
P2860
Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cell-based screening identifie ...... betic endothelial dysfunction.
@ast
Cell-based screening identifie ...... betic endothelial dysfunction.
@en
Cell-based screening identifie ...... betic endothelial dysfunction.
@nl
type
label
Cell-based screening identifie ...... betic endothelial dysfunction.
@ast
Cell-based screening identifie ...... betic endothelial dysfunction.
@en
Cell-based screening identifie ...... betic endothelial dysfunction.
@nl
prefLabel
Cell-based screening identifie ...... betic endothelial dysfunction.
@ast
Cell-based screening identifie ...... betic endothelial dysfunction.
@en
Cell-based screening identifie ...... betic endothelial dysfunction.
@nl
P2093
P2860
P356
P1433
P1476
Cell-based screening identifie ...... betic endothelial dysfunction.
@en
P2093
Ciro Coletta
Csaba Szabo
Domokos Gerö
Gabor Oláh
Katalin Módis
Kunihiro Suzuki
Petra Szoleczky
P2860
P304
P356
10.2337/DB12-0789
P407
P577
2012-12-07T00:00:00Z